Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
Also known as: Active polyarticular Juvenile idiopathic arthritis
Drug | Drug Name | Drug Description |
---|---|---|
DB06674 | Golimumab | A TNFα inhibitor used in the symptomatic treatment of various active inflammatory disorders, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB06674 | Golimumab | Tumor necrosis factor | target |